The goals of the Genetic analysis core are: 1) To obtain and process buccal cell specimens from 40,000 participants in the NHS to supplement the DNA obtained from collection; 2) To provide fast, efficient, and accurate genotyping to Project investigators at the lowest possible cost. The core will manage the dispatch of kits for cheek cell collection by mail, and will process and archive these on return; this will be accomplished in Year 1. In years 1-5 we will: 1) Conduct DNA extraction DNA extraction and genotyping for germline polymorphism in CYP1A2, and NAT1, NAT, MnSOD, and MTHFR (Project 1), CYP1A2, NAT1, NAT2, and MTHFR (Project 2), and GALT and AR (Project 3). Germline DNA will be extracted from stored buffy goats, cheek cell samples, and normal tissue from tumor blocks; 2) Assess methylation status of CpG islands in the promoter regions of ER and p16 (Project 1) and p16 (Project 2). The existence of the Core will permit genotyping to proceed, efficiently, and additional efficiencies will be achieved as several of the genotypes overlap between the projects permitting some economies of scale. The minimal geographic separation of the core facility from the investigators will also facilitate rapid communication of priorities for analyses, speedy interpretation of results of and resolution of any questions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA087969-01
Application #
6401643
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2000-09-12
Project End
2004-11-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Gaudet, Mia M; Gierach, Gretchen L; Carter, Brian D et al. (2018) Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype. Cancer Res 78:6011-6021
Zhang, Xuehong; Rice, Megan; Tworoger, Shelley S et al. (2018) Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med 15:e1002644
Cao, Yin; Wu, Kana; Mehta, Raaj et al. (2018) Long-term use of antibiotics and risk of colorectal adenoma. Gut 67:672-678
Khalaf, Natalia; Yuan, Chen; Hamada, Tsuyoshi et al. (2018) Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies. Gastroenterology 154:1380-1390.e5
Kensler, Kevin H; Beca, Francisco; Baker, Gabrielle M et al. (2018) Androgen receptor expression in normal breast tissue and subsequent breast cancer risk. NPJ Breast Cancer 4:33
Heng, Yujing J; Wang, Jun; Ahearn, Thomas U et al. (2018) Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Res Treat :
Farvid, Maryam S; Chen, Wendy Y; Rosner, Bernard A et al. (2018) Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow-up. Int J Cancer :
Li, Jun; Rice, Megan S; Huang, Tianyi et al. (2018) Circulating prolactin concentrations and risk of type 2 diabetes in US women. Diabetologia 61:2549-2560
O'Mara, Tracy A; Glubb, Dylan M; Amant, Frederic et al. (2018) Identification of nine new susceptibility loci for endometrial cancer. Nat Commun 9:3166
Tabung, Fred K; Wang, Weike; Fung, Teresa T et al. (2018) Association of dietary insulinemic potential and colorectal cancer risk in men and women. Am J Clin Nutr 108:363-370

Showing the most recent 10 out of 1708 publications